Cargando…
Evaluation of the Humoral Immune Response of a Heterologous Vaccination between BBIBP-CorV and BNT162b2 with a Temporal Separation of 7 Months, in Peruvian Healthcare Workers with and without a History of SARS-CoV-2 Infection
Information on the effects of a heterologous booster in adult patients first vaccinated with the BBIBP-CorV vaccine is limited. This prospective cohort study evaluated the humoral response of 152 healthcare workers (HCWs) from a private laboratory in Lima (Peru) before and after receiving the BNT162...
Autores principales: | Hueda-Zavaleta, Miguel, Gómez de la Torre, Juan C., Cáceres-Del Aguila, José Alonso, Muro-Rojo, Cecilia, De La Cruz-Escurra, Nathalia, Arenas Siles, Daniella, Minchón-Vizconde, Diana, Copaja-Corzo, Cesar, Bardales-Silva, Fabrizzio, Benites-Zapata, Vicente A., Rodriguez-Morales, Alfonso J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031938/ https://www.ncbi.nlm.nih.gov/pubmed/35455251 http://dx.doi.org/10.3390/vaccines10040502 |
Ejemplares similares
-
Humoral Immune Response Induced by the BBIBP-CorV Vaccine (Sinopharm) in Healthcare Workers: A Cohort Study
por: Gómez de la Torre, Juan C., et al.
Publicado: (2022) -
Humoral Response after a Fourth Dose with mRNA-1273 in Healthcare Workers with and without a History of SARS-CoV-2 Infection and Previously Vaccinated with Two Doses of BBIBP-CorV Plus BNT162b2 Vaccine
por: Gómez de la Torre, Juan C., et al.
Publicado: (2023) -
BBIBP-CorV: Hepatitis: case report
Publicado: (2022) -
BBIBP-CorV: Anterior uveitis: case report
Publicado: (2022) -
Persistence of immune responses to the Sinopharm/BBIBP‐CorV vaccine
por: Jeewandara, Chandima, et al.
Publicado: (2022)